MY117328A - Production process for intravenous immune serum globulin and resultant product. - Google Patents

Production process for intravenous immune serum globulin and resultant product.

Info

Publication number
MY117328A
MY117328A MYPI98005848A MYPI9805848A MY117328A MY 117328 A MY117328 A MY 117328A MY PI98005848 A MYPI98005848 A MY PI98005848A MY PI9805848 A MYPI9805848 A MY PI9805848A MY 117328 A MY117328 A MY 117328A
Authority
MY
Malaysia
Prior art keywords
production process
resultant product
immune serum
intravenous immune
serum globulin
Prior art date
Application number
MYPI98005848A
Inventor
Raja R Mamida
Bagdasarian Andranik
Canaveral Gorgonio
Kazuo Takechi
Original Assignee
Alpha Therapeutic Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alpha Therapeutic Corp filed Critical Alpha Therapeutic Corp
Publication of MY117328A publication Critical patent/MY117328A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065—Purification, fragmentation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Abstract

A PROCESS FOR PRODUCING AN INTRAVENOUSLY-ADMINISTRABLE GAMMA GLOBULIN SOLUTION SUBSTANTIALLY FREE OF CONTAMINATING VIRUSES BY HEAT TREATING FOR VIRAL INACTIVATION AND FRACTIONATING AN IMPURE GAMMA GLOBULIN SOLUTION AND THEN TREATING THE PURIFIED GAMMA GLOBULIN WITH A SOLVENT-DETERGENT FOR FURTHER VIRAL INACTIVATION.
MYPI98005848A 1997-12-24 1998-12-23 Production process for intravenous immune serum globulin and resultant product. MY117328A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US99795297A 1997-12-24 1997-12-24

Publications (1)

Publication Number Publication Date
MY117328A true MY117328A (en) 2004-06-30

Family

ID=25544595

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI98005848A MY117328A (en) 1997-12-24 1998-12-23 Production process for intravenous immune serum globulin and resultant product.

Country Status (15)

Country Link
EP (1) EP0971727A4 (en)
JP (1) JP2001514672A (en)
KR (1) KR20000075562A (en)
CN (1) CN1214042C (en)
AR (1) AR018260A1 (en)
AU (1) AU747893B2 (en)
BR (1) BR9807598A (en)
CA (1) CA2281938A1 (en)
CO (1) CO4970799A1 (en)
IL (1) IL131471A0 (en)
MY (1) MY117328A (en)
RU (1) RU2198668C2 (en)
TW (1) TW546144B (en)
UA (1) UA64742C2 (en)
WO (1) WO1999033484A1 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2527915T3 (en) 1998-06-09 2015-02-02 Csl Behring Ag Liquid immunoglobulin G (IgG) product
EP1185290A4 (en) * 1999-06-15 2005-08-31 Alpha Therapeutic Corp Manufacturing method for intravenous immune globulin and resultant product
JP2004525077A (en) * 2000-09-28 2004-08-19 リサーチ　コーポレイション　テクノロジーズ，インコーポレイテッド Treatment of immune-mediated diseases by oral administration of immunoglobulin G enriched plasma fraction
ES2184594B1 (en) * 2001-01-17 2004-01-01 Probitas Pharma Sa PROCEDURE FOR THE PRODUCTION OF GAMMAGLOBULINA G HUMANA INACTIVADA OF VIRUS.
US6893639B2 (en) 2001-10-19 2005-05-17 Hemacare Corporation Method for high yield purification of immune globulins from blood plasma and blood plasma intermediates
ES2558303T3 (en) 2002-09-11 2016-02-03 Chugai Seiyaku Kabushiki Kaisha Protein Purification Method
TWI320788B (en) 2005-05-25 2010-02-21 Hoffmann La Roche Method for the purification of antibodies
KR100791502B1 (en) * 2006-09-29 2008-01-03 한스바이오메드 주식회사 Production methods of virus inactivated and cell-free body implant
EP2350271B1 (en) * 2008-11-20 2016-01-27 Biogen MA Inc. Arginine inactivation of enveloped viruses
IL212911A0 (en) * 2011-05-16 2011-07-31 Omrix Biopharmaceuticals Ltd Immunoglobulin reduced in thrombogenic contaminants and preparation thereof
ES2381828B1 (en) * 2012-03-20 2012-11-16 Grifols, S.A. PROCEDURE TO OBTAIN A COMPOSITION OF IgG THROUGH THERMAL TREATMENT
ES2785375T3 (en) 2014-03-11 2020-10-06 Green Cross Holdings Corp Immunoglobulin purification procedure
CN107880116B (en) * 2016-09-30 2023-02-03 盖立复集团公司 Method for producing immunoglobulins

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2604759C2 (en) * 1976-02-07 1983-06-01 SCHURA Blutderivate GmbH & Co KG, 4150 Krefeld Method of Obtaining IV Compatible Gamma Globulins
US4820805A (en) * 1983-07-14 1989-04-11 New York Blood Center, Inc. Undenatured virus-free trialkyl phosphate treated biologically active protein derivatives
US4835257A (en) * 1984-07-07 1989-05-30 Armour Pharma Gmbh Process for preparing gamma globulin suitable for intravenous administration using peg and a citrate buffer
FR2582515B1 (en) * 1985-05-30 1988-11-04 Merieux Inst PROCESS FOR THE PREPARATION OF GAMMA-GOBULINS ADMINISTRABLE BY THE INTRAVENOUS ROUTE AND GAMMA-GLOBULINS OBTAINED
JPH0662436B2 (en) * 1986-05-19 1994-08-17 株式会社ミドリ十字 Method for producing intravenous immunoglobulin preparation
US4841023A (en) * 1986-06-25 1989-06-20 New York Blood Center, Inc. Inactivation of viruses in labile protein-containing compositions using fatty acids
DE3825429C2 (en) * 1988-07-27 1994-02-10 Biotest Pharma Gmbh Method for producing an intravenously administrable polyclonal immunoglobulin preparation with a high IgM content
JP2965069B2 (en) * 1989-01-13 1999-10-18 吉富製薬株式会社 Method for producing protein-containing composition
EP0378208B2 (en) * 1989-01-13 2003-01-15 Mitsubishi Pharma Corporation Production method for protein-containing composition
CA2034489C (en) * 1989-06-15 1996-07-16 Michael E. Hrinda Methods for the inactivation of viruses in viral-contaminated pharmaceutical compositions
US5177194A (en) * 1990-02-01 1993-01-05 Baxter International, Inc. Process for purifying immune serum globulins
JP3145696B2 (en) * 1990-10-05 2001-03-12 日本ケミカルリサーチ株式会社 Method for producing secretory immunoglobulin A preparation
US5110910A (en) * 1991-03-25 1992-05-05 Miles Inc. Virucidal euglobulin precipitation
DE4431833C1 (en) * 1994-09-07 1995-05-18 Blutspendedienst Der Drk Lande Prepn. of an anti-haemophilic factor from a cryo-precipitate
JP4003235B2 (en) * 1994-09-30 2007-11-07 三菱ウェルファーマ株式会社 Method for producing intravenous immunoglobulin preparation

Also Published As

Publication number Publication date
WO1999033484A1 (en) 1999-07-08
CN1252729A (en) 2000-05-10
KR20000075562A (en) 2000-12-15
EP0971727A1 (en) 2000-01-19
IL131471A0 (en) 2001-01-28
TW546144B (en) 2003-08-11
CA2281938A1 (en) 1999-07-08
JP2001514672A (en) 2001-09-11
AU1703899A (en) 1999-07-19
UA64742C2 (en) 2004-03-15
RU2198668C2 (en) 2003-02-20
AR018260A1 (en) 2001-11-14
AU747893B2 (en) 2002-05-30
BR9807598A (en) 2000-02-22
CN1214042C (en) 2005-08-10
CO4970799A1 (en) 2000-11-07
EP0971727A4 (en) 2005-01-19

Similar Documents

Publication Publication Date Title
MY117328A (en) Production process for intravenous immune serum globulin and resultant product.
HU9503557D0 (en) Immunoglobulin g concentrate for therapeutical use and method for producing same
HUT75261A (en) Process for producing 1-hydroxy-alkylidene-1,1-bisphosphonic acids and intermediates thereof, trimers and tetramers of alkylpyrophosphonate and alkylpyrophosphate as intermediates
UA27732C2 (en) Process for preparation of a standardized human von willebrand factor concentrate and a concentrate prepared thereby
EP0128522A3 (en) High titer cytomegalovirus immune serum globulin and method of making same
NO178716C (en) Process for Preparing a Stable Concentrate of Factor VIII-von Willebrand Factor Complex
EP0168234A3 (en) Purification process for hepatitis surface antigen and product thereof
PL299346A1 (en) Method of theating articles of food and theirt byproducts, articles of food and their byproducts obtained thereby and use of adsorptive resins for treating articles of food and their byproducts
GB1488774A (en) Hepatitis b antigen and method of producing it
BR0010815A (en) Method of preparing viral doubly inactivated immune globulin for intravenous administration
ES8705230A1 (en) Process for preparing gamma-globulins supplied by intravenous administration and gamma-globulins obtained.
ZA971998B (en) Purification method.
SG86990A1 (en) Process for the quantitative purification of glycolipids
AU3876793A (en) Process for the inactivation of viruses in preparations of proteins
BR0011648A (en) Manufacturing method of intravenous immunoglobulin and resulting product
AU1516988A (en) Method of preparing highly purified alpha-1-proteinase inhibitor
FI893389A (en) FOERFARANDE FOER FRAMSTAELLNING AV FOSFATER GENOM SMAELTNING.
AU4811290A (en) A pure factor i protein and a process for producing said protein
PT79232A (en) Process for producing immune interferon and of pharmaceutical compositions containing the same
AU585480B2 (en) Process for the stabilization of hematim
HU9802975D0 (en) Recombinant avipox viruses, the culture of cells infected by these viruses, vaccines for poultry, transfer sequences for production of viruses and plas mids containing of these sequences and process for producing thereof and use of viruses as vectors